Satisfying QTPP of Erythropoietin Biosimilar by QbD through DoE-Derived Downstream Process Engineering

Well-characterized and scalable downstream processes for the purification of biologics are extremely demanding for delivering quality therapeutics to patients at a reasonable price. Erythropoietin (EPO) is a blockbuster biologic with diverse clinical applications, but its application is limited to f...

Descripción completa

Detalles Bibliográficos
Autores principales: Nag, Kakon, Sarker, Enamul Haq, Kumar, Samir, Chakraborty, Sourav, Khan, Maksusdur Rahman, Chowdhury, Mashfiqur Rahman, Roy, Rony, Roy, Ratan, Biswas, Bipul Kumar, Bappi, Emrul Hasan, Mohiuddin, Mohammad, Sultana, Naznin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10460001/
https://www.ncbi.nlm.nih.gov/pubmed/37631301
http://dx.doi.org/10.3390/pharmaceutics15082087

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10460001/
https://www.ncbi.nlm.nih.gov/pubmed/37631301
http://dx.doi.org/10.3390/pharmaceutics15082087

Ejemplares similares